Department of Biochemistry, Mount Sinai
School of Medicine of the City University of New York, New York,
New York 10029,1 and Molecular
Microbiology, Vrije Universiteit, Amsterdam, The
Netherlands2
 |
INTRODUCTION |
The sequence of a locus that
was reported as part of the Bacillus subtilis genome project
(21; GenBank accession no. Z93937 and Z93932
[some corrections to the original sequence were noted during the
present study and entered into the databank]) is of interest
in connection with monovalent cation resistance and cytoplasmic pH
regulation in adaption to high pH. This unusual cluster of genes is 5.9 kb long and is predicted to encode seven hydrophobic proteins that are
likely to be coordinately expressed as an operon. The special
interest in connection with alkali and monovalent cation resistance is
based on studies reported by others on diverse homologues of this
locus, i.e., a homologue from alkaliphilic Bacillus strain
C-125 encompassing only the first three genes (10) and full
operons designated pha (pH adaptation) from
Rhizobium meliloti (23) and designated
mnh from Staphylococcus aureus that complemented
a Na+/H+ antiporter-deficient Escherichia
coli strain (12). In the alkaliphilic Bacillus strain C-125 in which this gene family was first
identified (10, 16), a crossover event involving the first
gene of the partially cloned operon corrected a point mutation
in the chromosomal copy of a mutant that had a
nonalkaliphilic, pH homeostasis-negative, and
Na+/H+ antiporter-negative phenotype. By
contrast, the recently reported studies of the full homologue from
R. meliloti (23) arose from characterization of a
transposition mutant whose disruption of the first gene in the
operon, phaA, rendered it unable to invade nodule
tissue, exquisitely sensitive to inhibition by K+,
and deficient in diethanolamine-induced K+ efflux but
normal with respect to Na+-related properties. The data
presented by both sets of studies support the respective suggestions
that the first gene of the alkaliphile operon encodes an
Na+/H+ antiporter and that of the
pha operon encodes a K+/H+
antiporter. However, neither study included complementation of mutant phenotypes in trans without a recombination event.
This is particularly important with this operon because of
its unusual complexity compared to other monovalent
cation/H+ antiporter-encoding loci. Indeed, Hiramatsu et
al. (12) demonstrated that Na+-related functions
of the S. aureus mnh operon expressed in E. coli were dependent on the presence of more than just the
first gene (12). Also, as noted by the other
investigators (10, 23) and observed in our sequence
analysis of the B. subtilis operon, there is a
striking similarity between several of the genes of these
operons and those encoding subunits of proton-translocating NADH dehydrogenases (26, 28) and a recently analyzed,
putative proton-translocating formate hydrogenlyase system from
E. coli (2). Hiramatsu et al. (12)
proposed that the Na+/H+ antiporter is a novel
multisubunit secondary transporter that is energized conventionally by
the proton motive force. It should not be ruled out, though, that
products of these new antiporter-encoding loci may form complexes that
under some conditions function as a primary ion extrusion or
exchange system that is energized directly, e.g., by electron
transport through Mrp components. Alternatively, the complexity of the
operon may reflect the presence of genes that encode diverse
transporters whose functions all relate to a particular stress. Such an
operon might also include specific regulators, sensors,
assembly factors, or chaperones that are stable under that stress
condition and allow the function of the transporters. This would result
in an interdependence among the individual gene products of the type
suggested for mnh (12).
In the present studies on the B. subtilis
operon, we have examined the properties of a mutant with a null
mutation in the operon. We have also focused on the first gene
and the final two genes of the operon, generating mutants that
could be complemented in trans. Since roles in pH
homeostasis and Na+ and cholate resistance were found, the
name mrp is proposed for the operon, for "multiple
resistance and pH adaptation locus."
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
The wild-type and
mutant strains of B. subtilis used in this study are
listed in Table 1. The mrp
mutants included a null strain (VKN1), mutants with polar and nonpolar
mutations in mrpA (VK6 and VK1), a mutant with a polar
mutation in mrpF (VK15), and a double mutant with mutations
in mrpA and tetA(L) (VK123); these mutants were
all made as described below. B. subtilis JC112 is a
wild-type strain in which the chromosomal tetA(L) locus was replaced with a chloramphenicol resistance cassette (5);
this strain was included in some of the growth studies and in the pH homeostasis studies. Routine growth of all these strains was carried out at 30°C, with shaking, in TKM medium (Tris-potassium malate, no
added Na+). For growth experiments, pH shift experiments,
and solute efflux experiments, either TTM medium (Tris-Tris malate, 1 mM potassium phosphate, no added Na+) or TKM medium,
described previously (5), served as the base to which the
indicated additions were made for specific protocols; yeast extract was
added to these media at 0.1% (wt/vol). In completely synthetic media
(including Spizizen salts-based media [24]) that
supported rapid growth of the wild type and substantial growth of
JC112, VK1, and VK15, VK6 did not exhibit significant growth. The
inability of VK6 to grow in such media was not overcome by the use of
glucose instead of malate as the carbon source or by elevation of the
phosphate concentration (data not shown). For experiments including
constructs into which mrp genes were introduced into the
amyE locus under control of the pspac
promoter, 200 µM isopropyl-
-D-thiogalactoside (IPTG)
was included in the growth media as well as in the dilution buffers for
efflux experiments. If the IPTG was omitted, there was only marginally
significant complementation by the constructs that complemented
substantially or completely when IPTG was added.
Complementation and resistance studies.
For the
determinations of NaCl sensitivity, TKM medium at pH 7.0 or pH 8.3 was
supplemented with different concentrations of NaCl. Cultures (2 ml)
were grown in 15-ml conical tubes with shaking at 30°C. They were
inoculated with 10 µl of an 8-h culture grown in TKM medium (pH 7.0),
and the absorbance at 600 nm was read after 15 h. The MIC was
defined as the minimal NaCl concentration that completely prevented
growth after 15 h of incubation. For the determination of growth
sensitivity to cholate, 2 ml of TKM (pH 7.0), with or without the
addition of 0.08% (wt/vol) cholate, was inoculated with 50 µl of an
8-h culture grown on TKM (pH 7.0). The incubation, in 15-ml conical
tubes, was conducted with shaking at 30°C. The absorbance at 600 nm
was recorded after 6 h of incubation.
Construction of mutant strains.
For each type of mutant, the
phenotype of the strain used in the studies was the same as several
others from the construction protocol. Each mutant that was used in the
subsequent studies was shown to contain the expected sequence. The
sequencing was conducted at the Utah State Biotechnology Center (Logan,
Utah) with an ABI-100 model 377 Sequencer.
(i) The mrp operon null strain, VKN1.
Strain VKN1 was constructed by gene splicing via overlap extension
(gene SOEing), as described previously (13). Two independent PCRs were performed on wild-type DNA with the sets of primers shown in Fig. 1, BSMRPNE1 and
BSMRPNR, and BSMRPNF and BSMRPNB2. BSMRPNE1
(5'-GGAATCCAGCTGCGGCTGTCAAGTAT-3') corresponded
to the complementary sequence of bp 9563 to 9581 of the database entry GenBank accession no. Z93937 and additional nucleotides containing an
EcoRI site. The restriction enzyme sites are underlined.
BSMRPNR (5'-TTCTCATCAAGCTTGACCCGGGCGCTTCGAACTGCTGTAATGGA-3')
corresponded to the complementary sequence of bp 7154 to
7171 of the database entry GenBank accession no. Z93932, bp 10358 to
10337 of the database entry GenBank accession no. Z93937, and
additional nucleotides containing a SmaI site in the middle
of the sequence. BSMRPNF
(5'-TCCATTAACAGCAGTTCGAAGCGTCCCGGGTCAAGCTTGATGAGAGAA-3') corresponded to the complementary sequence of bp 10337 to 10359 of the
database entry GenBank accession no. Z93937, bp 7171 to 7154 of the
database entry GenBank accession no. Z93932, and additional nucleotides
containing a SmaI site in the middle of the sequence.
BSMRPNB2 (5'-CGCGGATCCATCAGCAAAACGGAATCT-3') corresponded to the complementary sequence of bp 6313 to 6330 of
the database entry GenBank accession no. Z93932 and additional nucleotides containing a BglII site. The two purified PCR
products were used as a template for a second PCR with primers
BSMRPNE1 and BSMRPNB2. The purified PCR product of this
reaction was digested with EcoRI and BglII, and
then cloned into EcoRI-BamHI-digested pGEM11Zf(+)
(Apr; Promega). The recombinant plasmid was digested with
SmaI. A gene encoding Spcr (20) was
ligated to this linear plasmid, resulting in a recombinant plasmid
containing fragments upstream and downstream of the mrp operon with a Spcr gene between them instead of
mrp. After isolation, the recombinant plasmid was digested
with EcoRI and the linear plasmid was introduced into
wild-type B. subtilis. Mutants with deletions in the
mrp operon were identified by spectinomycin
resistance (150 µg/ml) and confirmed by PCR and then sequencing for
the strain used in the studies.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic diagram of the mrp locus showing
the sizes of the predicted open reading frames, the site of the
nonpolar mutation made in mutant strain VK1, and the sites of the
disruptions made in mutant strains VKN1, VK6, and VK15. Seven open
reading frames (mrpABCDEFG) are indicated, using homologues
from other bacteria, especially the R. meliloti pha region,
as part of the frame of reference. The open reading frames are shown as
open boxes, with the direction of transcription indicated
by the horizontal arrows within the boxes. An arrow emerging upward
from the fragment upstream of mrpA and pointing in the
direction of transcription indicates the putative
promoter (P). The SphI fragment deleted in VK1 to create a
nonpolar in-frame deletion is indicated by the thin bent line flanked
by dotted vertical lines. The sites disrupted by a spectinomycin
resistance cassette in strains VK6 and VK15 are shown by the open
arrows pointing upward. The replacement of the entire mrp
locus with a spectinomycin resistance cassette is indicated for VKN1.
The primers used to construct mutant strains and integration vectors in
this work are shown by horizontal arrows (see Materials and Methods).
|
|
(ii) Mutants of the wild type (VK6) and JC112 (VK123) with polar
disruptions in mrpA.
PCR was performed on purified
wild-type B. subtilis chromosomal DNA by using the
PCR primers BSMRP1 and BSMRP2. The forward primer,
BSMRP1 (5'-AGGAGGTCTTATCTTTGCAGCTC-3'), corresponded to the complementary sequence of bp 10449 to 10473 of the database entry
GenBank accession no. Z93937 and is at the 5' end of the region of
interest (Fig. 1). The reverse primer, BSMRP2
(5'-GGCATAATCGCCATCAGGCCGCC-3'), corresponded to the
complementary sequence of bp 11603 to 11581 of the same database entry.
After 25 cycles of amplification, the purified PCR product (1,155 bp)
was first ligated into HincII-digested pGEM11Zf(+)
(Apr; Promega). The recombinant plasmid was identified by
blue-white screening in E. coli DH5
. After isolation, the
plasmid was digested with AccI and a 46-bp
AccI-AccI fragment was removed from the middle of mrpA. The plasmid was then treated with mung bean
nuclease to generate blunt ends. A Spcr gene
(20) was ligated to this linear plasmid, resulting in a recombinant plasmid containing a fragment of
mrpA with a small deletion in a region into which a
Spcr gene had been introduced. After isolation, the
recombinant plasmid was digested with ScaI, whose site was
located in the Apr gene, and the linear plasmid was
introduced into wild-type B. subtilis and into the
tetA(L) mutant strain JC112 by competent cell transformation
(24). Mutants of each of these strains that were disrupted
in the mrpA locus were identified by spectinomycin resistance (150 µg/ml) and confirmed by PCR analysis.
(iii) Mutant strain with a polar disruption of mrpF
(VK15).
The strategy was the same as in the construction of the
polar mrpA mutants above, except that PCR primers BSMRP3
and BSMRP4 (Fig. 1) were used. The forward primer, BSMRP3
(5'-GTACTGTACTCTGTGCTGAGGATC-3'), corresponded to the
complementary sequence of bp 8437 to 8414 of the database entry GenBank
accession no. Z93932. The reverse primer, BSMRP4
(5'-AGCAAGAGAGGCTGATCTGTATATCCAGA-3'), corresponded to the
complementary sequence of bp 6992 to 7020. The purified PCR product was
ligated into pGEM11Zf(+), and a recombinant plasmid was isolated as
described above. This plasmid was digested with Tth111I,
whose site was located in the middle of mrpF. The
digested plasmid was then treated with mung bean nuclease to generate
blunt ends, and the same Spcr gene was ligated into the
disruption site. The introduction into wild-type B. subtilis and isolation and characterization of the mutants
followed the procedures used for isolation of mrpA mutants.
(iv) Nonpolar mutant VK1 with a deletion in mrpA.
An
in-frame deletion in mrpA of wild-type B. subtilis BD99 was made as follows. PCR was performed on wild-type
DNA using the PCR primers BSMRPAX1 and BSMRPAB2 (Fig. 1). The
forward primer, BSMRPAX1
(5'-CTAGTCTAGAAAGGAGGTCTTATCTTTGCAGCTC-3'), corresponded to
the complementary sequence of bp 10449 to 10473 of the database entry
GenBank accession no. Z93937 and additional nucleotides containing an
XbaI site. The reverse primer, BSMRPAB2
(5'-GAAGATCTCATTCATTCACCGCTTTCCCCTCCT-3'), corresponded to
the complementary sequence of bp 12848 to 12871 of the same database
entry and additional nucleotides creating a BglII site.
The purified PCR product was cloned into HincII-digested pGEM9Zf(
) (Apr; Promega). This recombinant plasmid was
digested with SphI, and a 705-bp
SphI-SphI fragment was removed from the middle of
mrpA. The plasmid was ligated to itself, resulting in a
recombinant plasmid containing a mrpA fragment with
an in-frame deletion. For isolation of that fragment, the recombinant
plasmid was digested with BglII and XbaI. The
fragment was then cloned into BglII-XbaI-digested pDH88. The resulting plasmid, pDHA1, was integrated into the
mrpA locus in the chromosome by a single crossover with
chloramphenicol resistance for selection (11). To prepare
strains that had lost the plasmid sequences, leaving a single mutant
mrpA allele, several independent recombinants from the
transformation with pDHA1 were grown under nonselective conditions
(i.e., in the absence of chloramphenicol), and plated on LBK (Luria
broth with KCl) plates. Colonies were screened for sensitivity to 100 mM Na+, and such strains were further tested for
chloramphenicol sensitivity, which would indicate loss of the plasmid.
PCR analyses were used for initial confirmation of the deletion and
were followed by sequencing.
Integration of selected mrp genes into the
amyE loci of particular mutant strains under a
pspac promoter.
Particular mutant strains
that had been prepared as described above were constructed with one or
more mrp genes integrated into the chromosomal
amyE locus behind an IPTG-inducible
pspac promoter. Plasmid pDR67 was used for these
constructions (14). This plasmid contains fragments of the
front and back ends of the amyE gene flanking a
chloramphenicol resistance (Cmr) gene and also contains the
pspac promoter upstream of a multiple-cloning site. For construction of a plasmid that was carrying an intact mrpA gene, PCR was performed on wild-type DNA with the PCR
primers BSMRPAX1 and BSMRPAB2 (Fig. 1). For construction of a
plasmid that was carrying an intact mrpF gene, PCR was
performed on wild-type DNA with the PCR primers BSMRPFX1 and
BSMRPFB2 (Fig. 1). The forward primer BSMRPFX1
(5'-CTAGTCTAGAAAAAGCCATACAGGAGGTGAGCC-3') corresponded to
the complementary sequence of bp 7733 to 7757 of the database entry
GenBank accession no. Z93932 and additional nucleotides containing an
XbaI site. The reverse primer BSMRPFB2
(5'-GAAGATCTTAGCGGTTTCGATCATTTTCG-3') corresponded to the
complementary sequence of bp 7443 to 7465 of the same database entry
plus additional nucleotides containing a BglII
site. For construction of a plasmid that was carrying intact
mrpF and mrpG genes together, PCR was performed
on wild-type DNA with PCR primers BSMRPFX1 and BSMRPGB2 (Fig.
1). The reverse primer BSMRPGB2
(5'-GAAGATCTAGCAAGAGAGGCTGATCTGTATATCCAGATG-3') corresponded
to the complementary sequence of bp 6991 to 7022 of the database entry
GenBank accession no. Z93932 plus additional nucleotides containing a
BglII site. Each amplified fragment was cloned into
XbaI-BglII-digested pDR67, yielding pDRA1
(mrpA), pDRF1 (mrpF), and pDRFG1
(mrpFG). Each plasmid DNA was linearized with
NruI and used to transform particular mutants to a
Cmr Amy
phenotype. The plasmids used in this
study are listed together with the bacterial strains in Table 1; the
ones used were all confirmed to have the correct sequence.
Northern analyses.
Northern analyses were as described
previously (7). An oligonucleotide probe was used.
Oligonucleotide BSMRPA (5'-TCATTCACCGCTTTTCCCCTCCT-3') corresponded to the complementary sequence of bp 12848 to 12871 of the database entry GenBank accession no. Z93937, a region downstream
of the point of disruption of the polar mrpA mutants. The
oligonucleotide was radiolabeled by incubation of
[
-32P]ATP and T4 polynucleotide kinase (New England
Biolabs) at 37°C for 30 min. Polynucleotide kinase was inactivated by
heating to 65°C for 5 min. The radiolabeled oligonucleotide was
separated from [
-32P]ATP by Microcon YM-3 centrifugal
filter devices (Amicon). Additional analyses were conducted with a
probe of 157 bp corresponding to a 5' region of mrpA
(sequence of bp 10450 to 10606 of GenBank accession no. Z93937).
Determination of the cytoplasmic pH after a pH shift from 7.5 to
8.5.
The pH of the cytoplasm was determined 10 min after a
sudden shift in external pH as described previously
(5). Briefly, cells were grown in, and then washed and
equilibrated with, TTM medium at pH 7.5. Additions of various
concentrations of choline chloride, KCl, or NaCl were made to the
equilibration buffer as indicated. Then the external pH was rapidly
adjusted to 8.5. After 10 min, the distribution of radiolabeled
methylamine was used to assay the presence or absence of a
transmembrane pH gradient, acid in; measurement of the precise external
pH during the assay then allowed calculation of the cytoplasmic pH
after corrections for binding that were conducted as described
previously (5).
Solute efflux assays.
For assays of Na+ or
cholate efflux, cells were grown to the mid-logarithmic phase in TKM
medium (pH 7.0), harvested, washed twice with 50 mM potassium
morpholinepropanesulfonate (MOPS) (pH 7.5), and resuspended to 20 mg of
protein/ml in the same buffer. The cells were starved and loaded
with 5 mM 22NaCl (10 µCi/ml) or 20 µM sodium
[14C]cholate (1 µCi/ml) for 2 h. After
starvation and loading, the cells in Na+ efflux experiments
were diluted 1:100 into 50 mM potassium-MOPS (pH 7.5) plus 5 mM NaCl.
For cholate efflux experiments, 5 µl of cells was diluted into 500 µl of 50 mM potassium-MOPS (pH 7.5). The samples were vacuum
filtered at various times onto Millipore HAWP 0.45-µm-pore-size
filters, washed with 5 ml of buffer, dried, and counted by liquid
scintillation. Where indicated, either 10 µM carbonyl cyanide
p-chlorophenylhydrazone (CCCP) or 10 mM KCN was added for 15 min of preincubation to the cell suspension and was also included in
the dilution buffer. Also, where indicated, 10 mM glucose was added to
the dilution buffer. Protein concentrations in this and other assays
were determined by the method of Lowry et al. (17) with egg
white lysozyme as the standard.
 |
RESULTS |
Northern analyses of the wild type and potentially polar mutants
with mutations in the mrp locus.
Northern analyses
were conducted to confirm the expectation that the mrp genes
were expressed as an operon, VKN1 was a null strain for
mrp, and VK6 was a polar mrpA mutant in contrast
to VK1. As shown in Fig. 2, it proved
difficult to visualize Northern data from the wild type, VK6, and VKN1,
as well as VK1 and VK15. Under conditions of long exposures with both
the oligonucleotide probe and DNA probes to 3' and 5' regions of
mrpA, the wild type exhibited a band of 5.9 kb, which would
correspond to the expected length of a transcript of all seven
mrp genes. Under such conditions, VK6 exhibited a faint band
at the predicted position for that construct. VK1 and VK15 evidently
showed great overexpression of a species of the same size as each other
and a little smaller than that of the wild type; the degree of
overexpression made its measurement difficult. In other experiments,
the size of the VK1 transcript was more clearly seen as predicted and
that of VK15 was consistent with a polar mrpF mutation. In
no instance was a band attributable to mrp observed in the
null strain VKN1 (data not shown). In the particular experiment shown
in Fig. 2, the oligonucleotide probe to a region at the 3' end of
mrpA was used and conditions were chosen such that the wild
type was underexposed, with the 5.9-kb band just discernible in the
wild type but not in VKN1 or even the polar VK6 mutant. This condition
made it possible to see the distinction between the large top band and
the ribosomal bands in VK1 and VK15; these highly expressed top
bands were a little less than 5.9 kb and of similar size.
Ultimately it will be of interest to investigate the mechanism of
mrp overexpression in nonfunctional mutants and whether it
is mediated by cytoplasmic Na+ levels.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
Northern blot analysis of mRNA in the wild type (BD99),
mrpA mutants VK1 and VK6, mrpF mutant VK15, and
null mutant VKN1. The formaldehyde-agarose isolated RNA was probed with
the end-labeled 5' oligonucleotide probe described in Materials and
Methods. The 23S and 16S rRNA bands are indicated. The top arrow
indicates the position corresponding to 5.9 kb.
|
|
Na+ sensitivity.
As shown in Table
2, the null mutant VKN1 was exquisitely
sensitive to growth inhibition by Na+. All the other VK
mutant strains, while not as sensitive as VKN1, exhibited
pronounced Na+ sensitivity relative to both the wild
type and the moderately Na+-sensitive
tetA(L)-disrupted strain, JC112. TetA(L) is a
multifunctional antiporter that catalyzes the efflux of a
cobalt-tetracycline complex, Na+, or K+
in exchange for protons (3, 5, 6). The double mutant, VK123, in which a polar mrpA mutation identical to that in
VK6 was introduced into JC112, exhibited the same Na+
sensitivity as VK6. The Na+ sensitivity in mrp
mutants was particularly increased at pH 8.3, indicating that the
Na+ extrusion function of the operon is
particularly important at elevated pH. Interestingly, VK1 was more
sensitive than VK6 at pH 7.0. This suggests that one of the
mrp genes downstream of mrpA, whose expression is
reduced in polar VK6 relative to VK1, might catalyze the uptake of
Na+ at neutral pH, e.g., in symport with another solute. An
inducible mrpA construct was introduced into the
amyE loci of the null mutant (VKN1) as well as the polar
(VK6) and nonpolar (VK1) mutants that had disruptions in their
chromosomal mrpA. VKN1 exhibited no complementation, suggesting that one or more additional mrp gene products are
required for mrpA function. VK1 was complemented almost to
wild-type levels at pH 7.0 and also exhibited substantial
complementation at pH 8.3. VK6 was also significantly complemented at
both pH 7.0 and 8.3, although this complementation was lower than that
observed with VK1. The significant complementation of VK6, with its
reduced levels of mrpB to mrpG, by induced
expression of mrpA in trans is important. It
indicates that MrpA produced in stoichiometric excess with respect to
the other mrp gene products is functional in Na+
resistance. As shown below, the MrpA-dependent transport
Na+ activity in VK1/mrpA is elevated over that
observed in the wild type, consistent with the same conclusion.
An interesting set of observations on Na+ sensitivity was
made for VK15 and for complementation of both VK15 and VK6 by
introduction of an inducible mrpF or mrpFG
construct into the amyE locus. First, VK15 was just as
sensitive to Na+ as VK6 was. Induced expression of
mrpF increased the Na+ resistance of VK6 at pH
7.0 and 8.3, and the increase was not augmented in the strain
expressing mrpFG in trans. In VK15 itself, which
has a functional chromosomal mrpA, the induced expression of
mrpF in trans increased the Na+
resistance, but in this strain there was an augmentation when mrpFG was induced instead of mrpF. These findings
suggest that MrpF enhances Na+ resistance both in the
presence and in the absence of the putative antiporter-encoding
MrpA whereas MrpG enhances only in association with a functional MrpA.
Work on an earlier Na+ extrusion system of B. subtilis, the ATP-binding cassette-type natAB
transport system for Na+ extrusion, had indicated
that this system was inducible by ethanol and other membrane
perturbants and contributed to solvent resistance in part by excluding
Na+ that might leak in adversely. Several of the
mrp mutants were examined for their sensitivity to ethanol.
Although not shown, there was a qualitatively but not quantitatively
consistent sensitivity of the mutants relative to the wild type.
pH homeostasis phenotypes.
Earlier studies had shown that pH
7.5-equilibrated cells of JC112 were completely unable to regulate
their cytoplasmic pH upon a sudden shift in the external pH to 8.5 in
the presence of 100 mM K+ or Na+. These results
indicated a major role for TetA(L) in pH homeostasis at that level of
monovalent cation (5). Given the much greater Na+ sensitivity of all the mrp mutants than of
JC112, it seemed likely that any mrp-encoded antiporter
activity might establish lower cytoplasmic Na+
concentrations than could be accomplished by TetA(L) alone.
Therefore, pH shift experiments were conducted at 100, 25, and 10 mM Na+ or K+ as well as in the absence of added
Na+ or K+; in the latter experiments, choline
chloride was substituted for the sodium and potassium salts. Although
the results are not shown, none of the strains exhibited any capacity
for pH homeostasis after the pH shift when the choline salts were used;
i.e., after the shift, the cytoplasmic pH was the same as the new
external pH. As shown in Table 3, the
wild-type strain was capable of excellent pH homeostasis in the
presence of only 10 mM Na+, maintaining a cytoplasmic pH
close to the preshift level. Significant but more modest acidification
of the cytoplasm relative to the new external pH was observed in the
presence of 10 mM K+. The double mutant VK123, like
the tetA(L) mutant JC112 (data not shown), exhibited
neither Na+- nor K+-dependent pH
homeostasis at any of the monovalent cation concentrations. By
contrast, VKN1, VK1, VK6, and VK15 all showed a small deficit in
K+-dependent pH homeostasis. These strains also all
exhibited significant and comparable deficits in cytoplasmic pH
regulation relative to the wild type in the presence of 25 mM and,
especially, 10 mM Na+. Expression of mrpA in
trans in VK1 but not in VKN1 restored a capacity for
Na+-dependent pH homeostasis that was comparable to that of
the wild type.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Cytoplasmic pH measured in cells of wild type and various
mrp constructs after a shift in the external pH from 7.5 to 8.5a
|
|
Na+ efflux.
The apparent roles of MrpA in both
Na+ resistance and Na+-dependent pH
homeostasis were consistent with its being an
Na+/H+ antiporter, as has been proposed for the
homologues in alkaliphilic Bacillus strain C-125
(10) and S. aureus (12). To more
directly assay such an activity, cells of the wild type, VK1,
VK1/mrpA, VKN1, and VKN1/mrpA were partially
energy depleted and loaded with 5 mM 22Na+. The
cells were then diluted into buffers containing 5 mM nonradioactive Na+ in the presence or absence of other additions. The
concentration of 5 mM Na+ was chosen because it is well
below the concentration at which the TetA(L)
Na+/H+ antiporter activity is optimally active
(8). Indeed, as shown in Fig.
3, wild-type B. subtilis
exhibited fast efflux of Na+ that was significantly
stimulated by glucose addition and significantly inhibited by the
addition of either cyanide or the protonophore CCCP. By contrast,
Na+ efflux from VK1 cells exhibited a much slower
Na+ efflux which was not stimulated by glucose but was
enhanced by both cyanide and CCCP; most probably, in the only
partially starved cells, the cytoplasmic Na+ concentration
slightly exceeded the external Na+ concentration
after loading, and the stimulation by cyanide and CCCP represents a
stimulation of a leak of cytoplasmic Na+ down its
concentration gradient once the electrical potential component of the
proton motive force, positive out, is dissipated. In the
mrpA-complemented VK1, the Na+ efflux was faster
than in the wild-type cells, in both the absence and presence
of added glucose. Cyanide and CCCP both inhibited efflux
significantly but not completely. The Na+ efflux pattern of
VKN1 was similar to that of VK1 except for a slightly faster
Na+ efflux in VKN1; this, again, could be explained if the
complete deletion of VKN1 removes a Na+-coupled uptake
protein as well as Na+ efflux systems. Restoration of
mrpA to VKN1 increased the efflux rate slightly, but that
efflux rate was still stimulated rather than inhibited by both cyanide
and CCCP.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 3.
Efflux of Na+ from cells of wild type (wt),
VK1, VK1/mrpA, VKN1, and VKN1/mrpA. The cells
were washed, energy depleted, and loaded with 5 mM 22NaCl
as described in Materials and Methods. Efflux was initiated by diluting
the suspension 100-fold into buffer (containing 5 mM NaCl) and no
further additions ( ), buffer containing 10 mM glucose ( ), buffer
containing glucose plus 10 mM cyanide ( ), or buffer containing
glucose plus 10 µM CCCP ( ). Samples were taken at various times,
filtered, and washed, and the radioactivity was determined by liquid
scintillation counting.
|
|
MrpF-dependent resistance to cholate and efflux of Na+
and cholate.
The determinations of Na+ resistance in
mrpF-complemented VK6 indicated that there was an
enhancement of Na+ resistance when MrpF expression
was strongly induced in this MrpA
mutant at pH
7.0. Concomitant expression of MrpG did not increase the enhancement.
These results suggested that MrpF might be a transporter that catalyzed
Na+ efflux independently of MrpA. The greater
Na+ sensitivity of VKN1 relative to VK1 or VK6 (Table 2)
was similarly consistent with there being an mrp-encoded
Na+ efflux system in addition to MrpA. Since sequence
similarity was noted between MrpF and several eukaryotic
Na+-coupled bile acid transporters (9, 15, 26,
28) in BLAST analyses (1), the possibility was raised
that the Na+ and a bile salt type of compound might be
cosubstrates for an efflux system which could be energized by the
proton motive force. Cholate was used as the probe to assess this
hypothesis. The cholate resistance of various mrp mutant
strains was determined in comparison to the wild type and to each
other, with and without induced expression of mrpA or
mrpF in trans. The differences among the strains
examined with respect to growth inhibition by cholate were not
sufficient to affect the MIC in the same pronounced manner as was
observed among the strains for Na+ resistance. However, at
particular concentrations of cholate, e.g., 0.08% (wt/vol),
significant and highly reproducible differences were observed. As shown
in Fig. 4, VKN1, VK1, VK6, and VK15 all exhibited somewhat less growth than the wild-type strain at pH 7.0 in
the absence of added cholate; this is likely to have resulted in part
from inevitable contamination of the media with Na+. In
addition, and especially in the strains strongly expressing mrpA or mrpF, overexpression of a hydrophobic
protein may account for some of this small growth deficit. As expected,
the nonpolar mutant VK1 showed no increase in cholate inhibition
of growth relative to the wild type and the mrpA
status of the strain was similarly not a significant factor in cholate
sensitivity. In contrast, the cholate sensitivity of VKN1 and of
the polar VK6 mutant was more similar to that of VK15, i.e.,
significantly greater than the sensitivity of the wild type. The
same difference in sensitivity was not observed when taurocholate
was used instead of cholate (results not shown). The mrpA
status was again irrelevant with respect to significant effects on
cholate sensitivity in VK6. Expression of mrpF or of
mrpFG restored a comparable level of resistance to both VK6
and VK15 that was even greater than that of the wild type.
Neither mrpF nor mrpFG, however, restored cholate resistance to the mrp-null strain VKN1. These
findings were consistent with the function of MrpF as an
Na+-coupled cholate efflux system whose functional
expression requires at least low levels of one or more additional
mrp gene products but not of mrpA.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of cholate on the growth of wild-type (wt)
B. subtilis and several uncomplemented and complemented
strains with mutations in the mrp gene. Cells were grown in
TKM medium (pH 7.0) in the presence (hatched bars) or absence (open
bars) of 0.08% (wt/vol) cholate. The absorbance at 600 nm
(A600) was determined after 6 h of shaking
at 30°C. The results represent the mean of at least six
determinations; standard deviations are shown as error bars.
|
|
Efflux assays were undertaken to further document such
an MrpF-dependent activity. MrpF-dependent efflux of
22Na+ was examined in VK6 cells with and
without mrpF expression from the amyE locus. VK6
was used to eliminate the contribution of MrpA to the Na+
efflux, even though a modest level of residual MrpF function may exist
in VK6. The efflux was measured in cells that were partially energy depleted and loaded with 22Na+ in
either the presence or absence of 0.08% (wt/vol) cholate. As shown in
Fig. 5, VK6/mrpF exhibited
significantly faster Na+ efflux than VK6 did. No
stimulation of Na+ efflux was observed in the
presence of cholate. Efflux of cholate was monitored in cells of
VK15, with and without mrpF expression from the
amyE locus. The cells were preloaded with 20 µM
[14C]cholate in the presence or absence of 5 mM
Na+. As shown in Fig.
6, cholate efflux was significantly
faster in VK15/mrpF than in VK15. No effect of
Na+ addition was observed.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Efflux of Na+ from cells of VK6 and
VK6/mrpF in the presence or absence of cholate. The cells
were starved and loaded with 22NaCl, as described in
Materials and Methods, in the absence (open symbols) or presence (solid
symbols) of 0.08% (wt/vol) cholate. Efflux of Na+ from VK6
( , ) and VK6/mrpF ( , ) was assayed in the
presence of glucose, as in Fig. 3.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 6.
Efflux of cholate from cells of VK15 and
VK15/mrpF. The cells were energy depleted and loaded with 20 µM [14C]cholate as described in Materials and Methods.
Half of the cells were also loaded with 5 mM nonradioactive NaCl (solid
symbols), and half had no further additions (open symbols). Cholate
efflux was measured by sampling, as described in the legend to Fig. 3,
from the assay mixtures with VK15 ( , ) and VK15/mrpF
( , ).
|
|
 |
DISCUSSION |
The name mrp is proposed for the group of genes
whose analysis was initiated in this study because of the
multiple resistance and pH homeostasis-related functions of this
locus. MrpA is a strong candidate for a secondary
Na+/H+ antiporter which probably also has some
K+/H+ antiport capacity. A mutant with a
nonpolar mutation in mrpA (VK1) is highly sensitive to
Na+ and exhibits a defect in Na+-dependent pH
homeostasis at moderate concentrations of cation. This mutant exhibits
no proton motive force-dependent Na+ efflux from cells
preloaded with 5 mM Na+ and diluted into energization
buffer containing the same Na+ concentration. Induction of
mrpA in the amyE locus from the
pspac promoter restores close to wild-type
levels of Na+ resistance, Na+-dependent pH
homeostasis, and even faster protonophore-sensitive Na+
efflux than the wild type. Moreover, since mrpA expression
in trans in the polar VK6 mutant also complemented
significantly, MrpA is apparently catalytically competent in
stoichiometric excess over the other mrp gene products.
Together, these results are consistent with MrpA being an
Na+/H+ antiporter that can be energized by the
proton motive force and that can function independently of a fixed
complex with other mrp gene products. This would make MrpA
function similar to other prokaryotic Na+/H+
antiporters, three of which have rigorously been shown to catalyze antiport when purified and reconstituted alone in proteoliposomes (6, 22, 25). In studies of the S. aureus
homologue that were conducted entirely in E. coli, Hiramatsu
et al. (12) noted the requirement of multiple genes for
antiport function and proposed that the antiporter functions as a
multisubunit entity. The current finding that MrpA raises antiporter
activity upon overexpression in the wild type and, most impressively,
in the polar VK6 mutant with low levels of other
mrp genes is difficult to reconcile with a strict dependency
on a particular stoichiometric complex. The present studies do not
rule out the possibility, however, that under particular conditions
MrpA can also function within a specific stoichiometric relationship to
other mrp gene products in a membrane complex. Moreover, it
is conceivable that under these circumstances there is a primary mode
of energization via electron transport through the complex. A more
complete mutational and biochemical analysis of this complicated locus
is needed to fully resolve this important issue.
It is likely that at least one other mrp gene product is
needed as a chaperone or assembly factor for catalytic mrp
gene products, e.g., MrpA and MrpF. This would account for the
lack of complementation of VKN1. Expression of mrpA
from an IPTG-inducible promoter would have obviated the need
for any otherwise necessary transcriptional regulator. This level of
overexpression might also have allowed the assembly of significant
amounts of active MrpA even at lower levels of a chaperone or assembly
factor (i.e., as in VK6) than are essential for significant activity
when mrpA expression occurs at normal low levels. In VK15,
which has an intact mrpA gene but no mrpFG
function, the Na+ resistance was enhanced more by
mrpFG expression than by mrpF expression.
No difference was observed when the mrpA gene was absent.
This suggests that MrpG enhances MrpA stability, assembly, or function
when mrpA is expressed in its normal chromosomal
setting. We hypothesize that MrpG may play chaperone or
assembly roles for MrpA and perhaps for other
mrp-encoded structural gene products.
MrpF also appears catalytically competent when expressed from an
IPTG-inducible promoter in the VK15 mutant as well as in VK6, which has
no MrpA and greatly reduced levels of all other mrp gene
products. MrpF-dependent Na+ efflux and cholate efflux were
evident, but coupling of the two fluxes was not demonstrated. It may be
difficult to demonstrate cholate-dependent Na+ efflux,
because additional Na+ efflux systems are present in the
biological membranes. Because of the low concentration of cholate used,
it is similarly unlikely that Na+-dependent cholate efflux
could be demonstrated without developing a much more purified system.
It is of interest that a soil bacterium such as B. subtilis has a cholate efflux system and, as assessed from
the genome project annotations, may have more than this one (YocS;
GenBank accession no. Z99114). Whether this relates to the need to
extrude some endogenous substrate that has a related structure or to
the presence of cholate-like animal or plant products in the
natural environment is unknown. Other bacterial extrusion systems for
cholate have been reported (18, 19), and one of them is
induced by Na+, although the cation has not been shown to
be a substrate (18).
Both MrpA and MrpF may contribute to the Na+ resistance
role. If MrpF-dependent Na+-cholate efflux is coupled to
H+ uptake, they may both contribute to pH homeostasis as
well. Clarification of the relative contributions, under different
conditions, will require nonpolar mutations in each gene. Elucidation
of the roles of the other mrp gene products, including the
hypothesized chaperone role for MrpG, will similarly require
additional, single nonpolar mutations in those other genes.
Thus far, all the B. subtilis mrp gene functions are
linked by a relationship to Na+, and by far the dominant
phenotype associated with all the mutations in this locus is
Na+ sensitivity. After clarification of the full panoply of
functions of this locus, it will be of interest to examine the
differences between the B. subtilis operon and
those of other organisms in which the dominant physiological role
is different or predominantly related to a different cation, e.g.,
Na+-specific pH homeostasis in Bacillus strain
C-125 (10) and K+ sensitivity in R. meliloti (23). The mrp locus is the
third locus of B. subtilis that has been shown to
play a role in Na+ resistance. tetA(L) plays a
dominant role in Na+ (K+)-dependent pH
homeostasis in B. subtilis (5) and also
plays a significant role in Na+ exclusion in a range of
Na+ above 25 mM, but the present studies indicate that Mrp
function is a crucial adjunct to TetA(L) for the purposes
of Na+ resistance. Another Na+ extrusion
system, the ATP-binding cassette-type natAB of B. subtilis, is probably more specialized, becoming important
primarily under circumstances when the membrane integrity and/or the
proton motive force are reduced (4). Preliminary
experiments indicate, though, that mrp also plays a
role under such circumstances.
This work was supported by research grants GM28454 and
GM52837 from the National Institute of General Medical Sciences
(to T.A.K.) and a grant-in-aid for scientific research from the
Ministry of Education, Science and Culture of Japan (to M.I.).
While this article was under review, Kosono et al. (S. Kosono, S. Morotomi, M. Kitada, and T. Kudo, Biochim. Biophys. Acta 1409:171-175, 1999) reported the properties of a
mrpA mutant that was probably equivalent to the polar
mrpA mutant (VK6) described in this study; these
investigators found sensitivity to Na+ similar to that
observed in VK6.
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. F. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[Medline].
|
| 2.
|
Andrews, S. C.,
B. C. Berks,
J. McClay,
A. Ambler,
M. A. Quail,
P. Golby, and J. R. Guest.
1997.
A 12-cistron Escherichia coli operon (hyf) encoding a putative proton-translocating formate hydrogenlyase system.
Microbiology
143:3633-3647[Abstract].
|
| 3.
|
Cheng, J.,
A. A. Guffanti, and T. A. Krulwich.
1994.
The chromosomal tetracycline-resistance locus of Bacillus subtilis encodes a Na+/H+ antiporter that is physiologically important at elevated growth pH.
J. Biol. Chem.
269:27365-27371[Abstract/Free Full Text].
|
| 4.
|
Cheng, J.,
A. A. Guffanti, and T. A. Krulwich.
1997.
A two gene ABC-type transport system involved in Na+ extrusion by Bacillus subtilis is induced by ethanol and protonophore.
Mol. Microbiol.
23:1107-1120[Medline].
|
| 5.
|
Cheng, J.,
A. A. Guffanti,
W. Wang,
T. A. Krulwich, and D. H. Bechhofer.
1996.
Chromosomal tetA(L) gene of Bacillus subtilis: regulation of expression and physiology of a tetA(L) deletion strain.
J. Bacteriol.
178:2853-2860[Abstract/Free Full Text].
|
| 6.
|
Cheng, J.,
D. B. Hicks, and T. A. Krulwich.
1996.
The purified Bacillus subtilis tetracycline efflux protein TetA(L) reconstitutes both tetracycline-cobalt/H+ and Na+(K+)/H+ exchange.
Proc. Natl. Acad. Sci. USA
93:14446-14451[Abstract/Free Full Text].
|
| 7.
|
Dimari, J. F., and D. Bechhofer.
1993.
Initiation of mRNA decay in Bacillus subtilis.
Mol. Microbiol.
7:705-717[Medline].
|
| 8.
|
Guffanti, A. A., and T. A. Krulwich.
1995.
Tetracycline/H+ antiport and Na+/H+ antiport catalyzed by the Bacillus subtilis TetA(L) transporter expressed in Escherichia coli.
J. Bacteriol.
177:4557-4561[Abstract/Free Full Text].
|
| 9.
|
Hagenbuch, B.,
B. Stieger,
M. Foguet,
H. Lubbert, and P. J. Meier.
1991.
Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.
Proc. Natl. Acad. Sci. USA
88:10629-10633[Abstract/Free Full Text].
|
| 10.
|
Hamamoto, T.,
M. Hashimoto,
M. Hino,
M. Kitada,
Y. Seto,
T. Kudo, and K. Horikoshi.
1994.
Characterization of a gene responsible for the Na+/H+ antiporter system of alkalophilic Bacillus species strain C-125.
Mol. Microbiol.
14:939-946[Medline].
|
| 11.
|
Henner, D. J.
1990.
Inducible expression of regulatory genes in Bacillus subtilis.
Methods Enzymol.
185:223-228[Medline].
|
| 12.
|
Hiramatsu, T.,
K. Kodama,
T. Kuroda,
T. Mizushima, and T. Tsuchiya.
1998.
A putative multisubunit Na+/H+ antiporter from Staphylococcus aureus.
J. Bacteriol.
180:6642-6648[Abstract/Free Full Text].
|
| 13.
|
Horton, R. M.
1996.
In vitro recombination and mutagenesis of DNA.
Methods Mol. Biol.
67:141-149.
|
| 14.
|
Ireton, D. D.,
Z. Rudner,
K. J. Siranosian, and A. D. Grossman.
1993.
Integration of multiple developmental signals in Bacillus subtilis through Spo0A transcription factor.
Genes Dev.
7:283-294[Abstract/Free Full Text].
|
| 15.
|
Jacquemin, E.,
B. Hagenbuch,
B. Stieger,
A. W. Wolkoff, and P. J. Meier.
1994.
Expression cloning of a rat liver Na+-independent organic anion transporter.
Proc. Natl. Acad. Sci. USA
91:133-137[Abstract/Free Full Text].
|
| 16.
|
Kudo, T.,
M. Hino,
M. Kitada, and K. Horikoshi.
1990.
DNA sequences required for the alkalophily of Bacillus sp. strain C-125 are located close together on its chromosomal DNA.
J. Bacteriol.
172:7282-7283[Abstract/Free Full Text].
|
| 17.
|
Lowry, O. H.,
N. J. Rosebrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:265-275[Free Full Text].
|
| 18.
|
Ma, D.,
D. N. Cook,
M. Alberti,
N. G. Pon,
H. Nikaido, and J. E. Hearst.
1995.
Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.
Mol. Microbiol.
16:45-55[Medline].
|
| 19.
|
Mallonee, D. H., and P. B. Hylemon.
1996.
Sequencing and expression of a gene encoding a bile acid transporter from Eubacterium sp. strain VPI 12708.
J. Bacteriol.
178:7053-7058[Abstract/Free Full Text].
|
| 20.
|
Murphy, E.,
L. Huwyler, and M. D. D. Bastos.
1985.
Transposon Tn554: complete nucleotide sequence and isolation of transposition defective and antibiotic-sensitive mutants.
EMBO J.
4:3357-3365[Medline].
|
| 21.
|
Oudega, B.,
G. Koningstein,
L. Rodriguez,
M. deSalas Ramon,
H. Hilbert,
A. Disterhoft,
T. M. Pohl, and T. Weitzenegger.
1997.
Analysis of the Bacillus subtilis genome: cloning and nucleotide sequence of a 62 kb region between 275 (rrnB) and 284 (pai).
Microbiology
143:2769-2774[Abstract].
|
| 22.
|
Pinner, E.,
E. Padan, and S. Schuldiner.
1994.
Kinetic properties of NhaB, a Na+/H+ antiporter from Escherichia coli.
J. Biol. Chem.
269:26274-26279[Abstract/Free Full Text].
|
| 23.
|
Putnoky, P.,
A. Kerezt,
T. Nakamura,
G. Endre,
E. Grosskopf,
P. Kiss, and A. Kondorosi.
1998.
The pha cluster of Rhizobium meliloti involved in pH adaptation and symbiosis encodes a novel type of K+ efflux system.
Mol. Microbiol.
28:1091-1101[Medline].
|
| 24.
|
Spizizen, J.
1958.
Transformation of biochemically deficient strains of Bacillus subtilis by deoxyribonucleate.
Proc. Natl. Acad. Sci. USA
44:1072-1078[Free Full Text].
|
| 25.
|
Taglicht, D.,
E. Padan, and S. Schuldiner.
1991.
Overproduction and purification of a functional Na+/H+ antiporter coded by nhaA(ant) from Escherichia coli.
J. Biol. Chem.
266:11289-11294[Abstract/Free Full Text].
|
| 26.
|
Thanassi, D. G.,
L. W. Cheng, and H. Nikaido.
1997.
Active efflux of bile salts by Escherichia coli.
J. Bacteriol.
179:2512-2518[Abstract/Free Full Text].
|
| 27.
|
Weidner, U.,
S. Geier,
A. Ptock,
T. Friedrich,
H. Leif, and H. Weiss.
1993.
The gene locus of the proton-translocating NADH:ubiquinone oxidoreductase in Escherichia coli.
J. Mol. Biol.
233:109-122[Medline].
|
| 28.
|
Wong, M. H.,
P. Oelkers,
A. L. Craddock, and P. A. Dawson.
1994.
Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter.
J. Biol. Chem.
269:1340-1347[Abstract/Free Full Text].
|
| 29.
|
Yagi, T.
1993.
The bacterial energy-transducing NADH-quinone oxidoreductases.
Biochim. Biophys. Acta
1141:1-17[Medline].
|